As of July 14, 2026, IO Biotech, Inc. (IOBT) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. IO Biotech, Inc. has a market capitalization of $3.45M, 71.95M shares outstanding, 13 institutional holders tracked. Key dilution vectors include approximately 4 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
60%
🔄 Reverse Split
70%
• 50-day avg $0.23 below $1 exchange minimum
• Only 4 months cash — financial pressure
🔁 Convertible Conversion
60%
• Major convertible overhang: 261% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise
35%
• Low cash runway: 4 months remaining
💹 Market Data
Market Cap$3.45M
Shares Outstanding71.95M
Float38.31M
Cash$30.66M
Debt$16.66M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 44.4% shares (2026Q1 vs prior)
13 institutional holders · 4.82M shares
#1
MORGAN STANLEY
1.41M shares
#2
Ikarian Capital, LLC
1.39M shares
#3
BOOTHBAY FUND MANAGEMENT, LLC
451.9K shares
📉 Short Interest
Short Interest2.15M
Days to Cover1.0
% of Float5.6%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Sep 30, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for IOBT Shareholders
IO Biotech, Inc. (IOBT) has a DilutionScore of 65/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.
Cash runway is a key watch item: IOBT has approximately 4 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.
DilutionWatch tracks over 25 SEC filing types for IOBT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for IOBT alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track IOBT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IOBT — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for IOBT
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.